High tryptophan diet reduces CA1 intraneuronal β-amyloid in the triple transgenic mouse model of Alzheimer's disease

Aging Cell

Volumn 11, Issue 5, 2012, Pages 810-822

  Noristani, Harun N ^a   Verkhratsky, Alexei ^a,b,c,d   Rodríguez, José J ^b,c,d,e  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b BASQUE FOUNDATION FOR SCIENCE   (Spain)

^c UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^d HOSPITAL DONOSTIA   (Spain)

^e INSTITUTE OF EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

Alzheimer's disease; Hippocampus; L tryptophan diet; Raphe nucleus; Serotonin; Serotonin transporter

Indexed keywords

AMYLOID BETA PROTEIN; SEROTONIN TRANSPORTER; TRYPTOPHAN;

ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DENTATE GYRUS; DIETARY INTAKE; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA3 REGION; HISTOPATHOLOGY; LEARNING; MALE; MEDIAN RAPHE NUCLEUS; MEMORY; MOUSE; NEUROFIBRILLARY TANGLE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; SENILE PLAQUE; SEROTONINERGIC NERVE CELL; STRATUM LACUNOSUM MOLECULARE; STRATUM PYRAMIDALE; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; CA1 REGION, HIPPOCAMPAL; DISEASE MODELS, ANIMAL; FEMALE; MALE; MICE; MICE, TRANSGENIC; NEURONS; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TRYPTOPHAN;

ANIMALIA; MUS MUSCULUS;

EID: 84866435706     PISSN: 14749718     EISSN: 14749726     Source Type: Journal    
DOI: 10.1111/j.1474-9726.2012.00845.x     Document Type: Article

References (50)

1. Albright MJ, Weston MC, Inan M, Rosenmund C, Crair MC (2007) Increased thalamocortical synaptic response and decreased layer IV innervation in GAP-43 knockout mice. J. Neurophysiol. 98, 1610-1625.
2. de Arruda Camargo GM, de Arruda Camargo LA, Saad WA (2010) On a possible dual role for the lateral septal area 5-HT(1A) receptor system in the regulation of water intake and urinary excretion. Behav. Brain Res. 215, 122-128.
3. Arsenault D, Julien C, Tremblay C, Calon F (2011) DHA improves cognition and prevents dysfunction of entorhinal cortex neurons in 3xTg-AD mice. PLoS One 6, e17397.
4. Bayliss DA, Li YW, Talley EM (1997) Effects of serotonin on caudal raphe neurons: inhibition of N- and P/Q-type calcium channels and the after hyperpolarization. J. Neurophysiol. 77, 1362-1374.
5. Bell JM, John AM (1981) Amino acid requirements of growing mice: arginine, lysine, tryptophan and phenylalanine. J. Nutr. 111, 525-530.
6. Billings LM, Oddo S, Green KN, McGaugh JL, LaFerla FM (2005) Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron 45, 675-688.
7. Braak E, Griffing K, Arai K, Bohl J, Bratzke H, Braak H (1999) Neuropathology of Alzheimer's disease: what is new since A Alzheimer?. Eur. Arch. Psychiatry Clin. Neurosci. 249(Suppl 3), 14-22.
8. Carew LB Jr, Alster FA, Foss DC, Scanes CG (1983) Effect of a tryptophan deficiency on thyroid gland, growth hormone and testicular functions in chickens. J. Nutr. 113, 1756-1765.
9. Cirrito JR, Disabato BM, Restivo JL, Verges DK, Goebel WD, Sathyan A, Hayreh D, D'Angelo G, Benzinger T, Yoon H, Kim J, Morris JC, Mintun MA, Sheline YI (2011) Serotonin signaling is associated with lower amyloid-beta levels and plaques in transgenic mice and humans. Proc. Natl Acad. Sci. USA 108, 14968-14973.
10. Cooper JR, Melcer I (1961) The enzymic oxidation of tryptophan to 5-hydroxytryptophan in the biosynthesis of serotonin. J. Pharmacol. Exp. Ther. 132, 265-268.
11. Coskun S, Ozer C, Gonul B, Take G, Erdogan D (2006) The effect of repeated tryptophan administration on body weight, food intake, brain lipid peroxidation and serotonin immunoreactivity in mice. Mol. Cell. Biochem. 286, 133-138.
12. De Marte ML, Enesco HE (1986) Influence of low tryptophan diet on survival and organ growth in mice. Mech. Ageing Dev. 36, 161-171.
13. Esler WP, Wolfe MS (2001) A portrait of Alzheimer secretases - new features and familiar faces. Science 293, 1449-1454.
14. Fadda F (2000) Tryptophan-free diets: a physiological tool to study brain serotonin function. News Physiol. Sci. 15, 260-264.
15. Haider S, Khaliq S, Haleem DJ (2007) Enhanced serotonergic neurotransmission in the hippocampus following tryptophan administration improves learning acquisition and memory consolidation in rats. Pharmacol Rep. 59, 53-57.
16. Jenkins TA, Elliott JJ, Ardis TC, Cahir M, Reynolds GP, Bell R, Cooper SJ (2010) Tryptophan depletion impairs object-recognition memory in the rat: reversal by risperidone. Behav. Brain Res. 208, 479-483.
17. Ju CY, Tsai CT (1995) Serotonergic mechanisms involved in the suppression of feeding by 5-HTP in rats. Chin. J. Physiol. 38, 235-240.
18. Kasa P, Rakonczay Z, Gulya K (1997) The cholinergic system in Alzheimer's disease. Prog. Neurobiol. 52, 511-535.
19. Knight EM, Verkhratsky A, Luckman SM, Allan SM, Lawrence CB (2012) Hypermetabolism in a triple-transgenic mouse model of Alzheimer's disease. Neurobiol. Aging 33, 187-193.
20. Konigsmark BW (1970). Methods for the Counting of Neurones. New York: Springer-Verlag.
21. Lauder JM (1990) Ontogeny of the serotonergic system in the rat: serotonin as a developmental signal. Ann. N. Y. Acad. Sci. 600, 297-313; discussion 314.
22. Levkovitz Y, Richter-Levin G, Segal M (1994) Effect of 5-hydroxytryptophane on behavior and hippocampal physiology in young and old rats. Neurobiol. Aging 15, 635-641.
23. Lyketsos CG, Olin J (2002) Depression in Alzheimer's disease: overview and treatment. Biol. Psychiatry 52, 243-252.
24. Masters CL, Multhaup G, Simms G, Pottgiesser J, Martins RN, Beyreuther K (1985) Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels. EMBO J. 4, 2757-2763.
25. Miguel-Hidalgo JJ, Alvarez XA, Cacabelos R, Quack G (2002) Neuroprotection by memantine against neurodegeneration induced by beta-amyloid (1-40). Brain Res. 958, 210-221.
26. Mossello E, Boncinelli M, Caleri V, Cavallini MC, Palermo E, Di Bari M, Tilli S, Sarcone E, Simoni D, Biagini CA, Masotti G, Marchionni N (2008) Is antidepressant treatment associated with reduced cognitive decline in Alzheimer's disease? Dement. Geriatr. Cogn. Disord. 25, 372-379.
27. Mowla A, Mosavinasab M, Haghshenas H, Borhani Haghighi A (2007) Does serotonin augmentation have any effect on cognition and activities of daily living in Alzheimer's dementia? A double-blind, placebo-controlled clinical trial J. Clin. Psychopharmacol. 27, 484-487.
28. Nelson RL, Guo Z, Halagappa VM, Pearson M, Gray AJ, Matsuoka Y, Brown M, Martin B, Iyun T, Maudsley S, Clark RF, Mattson MP (2007) Prophylactic treatment with paroxetine ameliorates behavioral deficits and retards the development of amyloid and tau pathologies in 3xTgAD mice. Exp. Neurol. 205, 166-176.
29. Noristani HN, Olabarria M, Verkhratsky A, Rodríguez JJ (2010) Serotonin fibre sprouting and increase in serotonin transporter immunoreactivity in the CA1 area of hippocampus in a triple transgenic mouse model of Alzheimer's disease. Eur. J. Neurosci. 32, 71-79.
30. Noristani HN, Meadows RS, Olabarria M, Verkhratsky A, Rodriguez JJ (2011) Increased hippocampal CA1 density of serotonergic terminals in a triple transgenic mouse model of Alzheimer's disease: an ultrastructural study. Cell Death Dis. 2, e210.
31. Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, LaFerla FM (2003) Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 39, 409-421.
32. Pakaski M, Bjelik A, Hugyecz M, Kasa P, Janka Z, Kalman J (2005) Imipramine and citalopram facilitate amyloid precursor protein secretion in vitro. Neurochem. Int. 47, 190-195.
33. Paxinos G, Franklin KBJ (2004) The Mouse Brain in Stereotaxic Coordinates, 2nd edn. San Diego, CA: Elesvier Academic Press.
34. Payton S, Cahill CM, Randall JD, Gullans SR, Rogers JT (2003) Drug discovery targeted to the Alzheimer's APP mRNA 5'-untranslated region: the action of paroxetine and dimercaptopropanol. J. Mol. Neurosci. 20, 267-275.
35. Pickel VM, Johnson E, Carson M, Chan J (1992) Ultrastructure of spared dopamine terminals in caudate-putamen nuclei of adult rats neonatally treated with intranigral 6-hydroxydopamine. Brain Res. Dev. Brain Res. 70, 75-86.
36. Porter RJ, Lunn BS, Walker LL, Gray JM, Ballard CG, O'Brien JT (2000) Cognitive deficit induced by acute tryptophan depletion in patients with Alzheimer's disease. Am. J. Psychiatry 157, 638-640.
37. Robert SJ, Zugaza JL, Fischmeister R, Gardier AM, Lezoualc'h F (2001) The human serotonin 5-HT4 receptor regulates secretion of non-amyloidogenic precursor protein. J. Biol. Chem. 276, 44881-44888.
38. Rodríguez JJ, Jones VC, Tabuchi M, Allan SM, Knight EM, LaFerla FM, Oddo S, Verkhratsky A (2008) Impaired adult neurogenesis in the dentate gyrus of a triple transgenic mouse model of Alzheimer's disease. PLoS One 3, e2935.
39. Schmitt JA, Wingen M, Ramaekers JG, Evers EA, Riedel WJ (2006) Serotonin and human cognitive performance. Curr. Pharm. Des. 12, 2473-2486.
40. Selkoe DJ (2002) Alzheimer's disease is a synaptic failure. Science 298, 789-791.
41. Stancampiano R, Melis F, Sarais L, Cocco S, Cugusi C, Fadda F (1997) Acute administration of a tryptophan-free amino acid mixture decreases 5-HT release in rat hippocampus in vivo. Am. J. Physiol. 272, R991-R994.
42. van der Stelt HM, Broersen LM, Olivier B, Westenberg HG (2004) Effects of dietary tryptophan variations on extracellular serotonin in the dorsal hippocampus of rats. Psychopharmacology 172, 137-144.
43. Supnet C, Bezprozvanny I (2010) The dysregulation of intracellular calcium in Alzheimer disease. Cell Calcium 47, 183-189.
44. Takahashi T, Miyazawa M (2011) Serotonin derivatives as inhibitors of beta-secretase (BACE 1). Pharmazie. 66, 301-305.
45. Umeda T, Tomiyama T, Sakama N, Tanaka S, Lambert MP, Klein WL, Mori H (2011) Intraneuronal amyloid beta oligomers cause cell death via endoplasmic reticulum stress, endosomal/lysosomal leakage, and mitochondrial dysfunction in vivo. J. Neurosci. Res. 89, 1031-1042.
46. Vertes RP, Fortin WJ, Crane AM (1999) Projections of the median raphe nucleus in the rat. J. Comp. Neurol. 407, 555-582.
47. Walsh DM, Selkoe DJ (2004) Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron 44, 181-193.
48. West MJ, Coleman PD, Flood DG, Troncoso JC (1994) Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease. Lancet 344, 769-772.
49. West MJ, Kawas CH, Martin LJ, Troncoso JC (2000) The CA1 region of the human hippocampus is a hot spot in Alzheimer's disease. Ann. N. Y. Acad. Sci. 908, 255-259.
50. Williams S, Serafin M, Muhlethaler M, Bernheim L (1998) The serotonin inhibition of high-voltage-activated calcium currents is relieved by action potential-like depolarizations in dissociated cholinergic nucleus basalis neurons of the guinea-pig. Eur. J. Neurosci. 10, 3291-3294.